Tirzepatide

---

Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that stimulates insulin secretion. 

usa manufactured tirzepatide 99.8% purity bulk supply semaglutide glp-1 peptide usa manufactured tirzepatide 99.8 purity

DMF + FDA EIR

• CAS:  2023788-19-2
• MF: C225H348N48O68
• MW: 4813.527
• Purity: 98%
• Solubility: Soluble in DMSO Appearance: Whitepowder
• Storage Temp: -20℃ ± 5℃ Indication: Type II diabetes
• usa manufactured tirzepatide 99.8% purity bulk supply semaglutide glp-1 peptide usa manufactured tirzepatide 99.8 purity